ロード中...
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
Background: Carfilzomib’s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib’s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadministration. Methods: Mice received: (i) saline; (ii) Cfz; (iii) Met; (i...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2020-07-01
|
| シリーズ: | International Journal of Molecular Sciences |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1422-0067/21/15/5185 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|